Coronation Fund Managers Ltd. Makes New $8.31 Million Investment in CVS Health Corporation $CVS

Coronation Fund Managers Ltd. purchased a new position in shares of CVS Health Corporation (NYSE:CVS) during the 3rd quarter, Holdings Channel.com reports. The institutional investor purchased 110,183 shares of the pharmacy operator’s stock, valued at approximately $8,307,000.

Other institutional investors have also recently made changes to their positions in the company. Long Island Wealth Management Inc. purchased a new position in CVS Health in the 3rd quarter valued at approximately $206,000. Assetmark Inc. raised its stake in shares of CVS Health by 12.5% in the third quarter. Assetmark Inc. now owns 678,558 shares of the pharmacy operator’s stock valued at $51,156,000 after acquiring an additional 75,603 shares in the last quarter. Atria Investments Inc grew its stake in CVS Health by 13.5% during the 3rd quarter. Atria Investments Inc now owns 83,633 shares of the pharmacy operator’s stock worth $6,305,000 after purchasing an additional 9,949 shares in the last quarter. Illinois Municipal Retirement Fund increased its holdings in CVS Health by 6.8% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 173,275 shares of the pharmacy operator’s stock worth $13,063,000 after purchasing an additional 11,030 shares during the period. Finally, Varma Mutual Pension Insurance Co raised its position in CVS Health by 22.5% in the 3rd quarter. Varma Mutual Pension Insurance Co now owns 203,173 shares of the pharmacy operator’s stock valued at $15,317,000 after purchasing an additional 37,300 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on CVS. Robert W. Baird boosted their price objective on CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of CVS Health in a report on Monday, December 29th. Jefferies Financial Group raised their price objective on shares of CVS Health from $92.00 to $98.00 in a report on Thursday, October 30th. Mizuho boosted their target price on shares of CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 10th. Finally, TD Cowen lifted their price target on CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, December 10th. Nineteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $94.91.

CVS Health Stock Up 0.7%

CVS opened at $78.45 on Friday. CVS Health Corporation has a one year low of $58.35 and a one year high of $85.15. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. The stock has a market capitalization of $99.80 billion, a P/E ratio of 56.85, a price-to-earnings-growth ratio of 0.82 and a beta of 0.50. The business’s 50-day simple moving average is $78.64 and its 200-day simple moving average is $76.24.

CVS Health (NYSE:CVS) last announced its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The firm had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business’s revenue was up 8.2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s payout ratio is presently 192.75%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.